Pricing

Log inSign up

Mersana Therapeutics

80 people · 0 jobs
‌

Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Martin Huber
President & Chief Executive Officer
Collapse
Brian C. Deschuytner
Chief Operating Officer & Chief Financial Officer
Timothy B. Lowinger
Chief Science & Technology Officer
Alejandra Carvajal
Svp, Chief Legal Officer
Mohan Bala
SVP & Chief Development Officer
Chuck Miller
Senior Vice President, Regulatory Affairs
Bradley J. Sumrow
Executive Medical Director
LZ
Lei Zhu
Executive Director
Caryn Crasnick-Maloney
Vice President, Human Resources

Board & advisors

DM
David Mott
Chairman
LA
Lawrence M. Alleva
Director
Willard H. Dere
Director
Allene M. Diaz
Director
Andrew Hack
Director
Kristen M. Hege
Director
Christoph Lengauer
Scientific Advisor
Howard A. Skip Burris III
Scientific Advisor
Peter A. Kiener
Scientific Advisor
KW
K. Dane Wittrup
Scientific Advisor

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

171 followers

Regeneron

144 followers

Illumina

81 followers

Agilent Technologies

89 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

49 followers

Explore companies